
Number of publications published per year by Shah, Naina. (Source : PubMed)

Distribution of publications types for Shah, Naina. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
Annals of surgical oncology
2010;17;4
Changes in glitazone use among office-based physicians in the U.S., 2003-2009.
Diabetes Care
2010;33;4
The Hox genes and their roles in oncogenesis.
Nat. Rev. Cancer
2010
[18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
Postgrad Med J
2010;86;1013
The safety and efficacy of benzodiazepine-modified treatments as a special form of unmodified ECT.
J ECT
2010;26;1
The depiction of electroconvulsive therapy in Hindi cinema.
J ECT
2010;26;1
Recognition and treatment of genitourinary complications in paediatric Crohn's disease using Infliximab.
Acta Paediatr.
2010


Sublingual versus vaginal misoprostol in the management of missed miscarriage.
J Pak Med Assoc
2010;60;2

Genome sequence of Cronobacter sakazakii BAA-894 and comparative genomic hybridization analysis with other Cronobacter species.
PLoS ONE
2010;5;3
Inpatient treatment of diabetic patients in Asia: evidence from India, China, Thailand and Malaysia.
Diabet. Med.
2010;27;1
[ See timeline ] [ See all publications ]
means that Shah, Naina has 37 papers cited a least 37 times - methodology
Nilay Shah and Saraswati Sukumar are at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.